Workenhe, S T <br/><br/>
Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells.  [electronic resource] 

 -  Oncogene  05 2016 
 - 2465-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2015.303  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Breast Neoplasms--pathology<br/>Camptothecin--analogs & derivatives<br/>Cell Line, Tumor<br/>Gene Knockout Techniques<br/>Genomics<br/>Herpesvirus 1, Human--physiology<br/>Humans<br/>Irinotecan<br/>Lentivirus--genetics<br/>Oncolytic Virotherapy<br/>Phosphorylation--drug effects<br/>RNA, Small Interfering--genetics<br/>Serine-Arginine Splicing Factors--deficiency<br/>Virus Replication--drug effects